跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-TOBRAMYCIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-TOBRAMYCIN
Authorized
STANDARD
TEVA-TOBRAMYCIN
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e34ab8fd355f5cf0
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
e34ab8fd355f5cf0
Drug Approval Canada Name
TEVA-TOBRAMYCIN
Product Name
TEVA-TOBRAMYCIN
Status
Marketed
Status Date
2016-02-03
Original Market Date
2016-02-03
Din
02389622
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
08:12.02
Atc Original
J01GB01 TOBRAMYCIN
Atc Name
j 01 gb 01
Aig Number
0110230004
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
TOBRAMYCIN (TOBRAMYCIN SULFATE)
60 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e34ab8fd355f5cf0
Type
Standard
Back to Health Canada Approvals